Two new optical devices could reduce the need to take tissue samples during medical examinations and operations and to then send them for testing – potentially speeding up diagnosis and treatment and cutting healthcare costs.
One is a lightweight handheld microscope designed to examine external tissue or tissue exposed during surgery. One example of its use could be to help surgeons compare normal and cancerous cells (during an operation). A key advantage is that the device can acquire high quality 3D images of parts of the body while patients are moving (eg due to normal breathing), enabling it to be applied to almost any exposed area of a patient’s body.
The second instrument, a tiny endoscope* incorporating specially designed optical fibres and ultraprecise control of the light coupled into it, has the potential to be inserted into the body to carry out internal cell-scale examination, for example during neurosurgery. Ultimately, this new approach may be able to provide high resolution images enabling surgeons to see inside individual cells at an adjustable depth beneath the surface of the tissue.
Both prototypes have been developed by Imperial College London in collaboration with the University of Bath and funded by the Engineering and Physical Sciences Research Council (EPSRC).
Currently, the diagnosis of many diseases requires taking a tissue specimen from the patient, preparing it in a laboratory, studying it under a microscope and then forwarding the results back to the clinician. The new devices, both of which harness a technique known as multiphoton excited fluorescence microscopy** to analyse individual cells in their native tissue, could be used in a consulting room or an operating theatre to help clinicians identify diseased tissue and provide a rapid diagnosis.
The handheld microscope incorporates a tracking mechanism that compensates for the patient’s movements, ensuring the generation of steady images. The endoscope is just a fraction of a millimetre in diameter and has no moving parts. Both these devices use novel multicore optical fibres developed by Imperial’s collaborators by the University of Bath.
Dr Chris Dunsby of Imperial College London, who has led the overall project, says:These new devices open up exciting possibilities in the field of in-situ diagnosis and could help improve patient care in the future.
Professor Jonathan Knight, who led the University of Bath team, says:
This has been a very exciting project which has enabled us to develop fibres with performance which we would have previously thought impossible.
After further development and refinement of the technology, clinical trials will explore the healthcare benefits of the two devices in more detail, with the goal of beginning to introduce them into clinical use within around 5-10 years.
The Latest on: Disease diagnosis
via Google News
The Latest on: Disease diagnosis
- Alzheimer’s disease: New blood tests offer hopeon January 18, 2022 at 2:05 am
Even in the prime of our lives, while we’re still healthy and clever, our brains may be secretly developing the deadly plaques and tangles of Alzheimer’s disease. The first sign of trouble is memory ...
- Liver cancer, diseases: A silent epidemic in PHon January 18, 2022 at 2:04 am
During the holiday seasons, many people celebrate by drinking, staying up late, and eating hearty meals—in the Philippines, some staple but heavy dishes included the crispy ...
- American Diagnosison January 18, 2022 at 2:02 am
American Diagnosis” is a conversation about some of the biggest public health challenges across the United States, with insights on topics from teen mental health to opioids and gun violence ...
- Relationsip Between Diabetes And Heart Disease; Know Ways To Prevent Cardiovascular Problemson January 18, 2022 at 1:52 am
Diabetics are at a higher risk of getting a silent heart attack. Here's the relationship between diabetes and heart disease.
- ACP releases two new clinical guidelines on the diagnosis and management of diverticulitison January 18, 2022 at 12:50 am
According to two new clinical guidelines from the American College of Physicians (ACP), uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics. Patients with ...
- New Clinical Investigation Approved for Treatment of Early-Stage Parkinson’s diseaseon January 17, 2022 at 6:24 pm
Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the global multi-center phase-II clinical trial of ...
- Exploring Attitudes Toward Medication Management, Caregiving in Parkinson Diseaseon January 17, 2022 at 11:45 am
Researchers wanted to understand more about the impact of medication management and other quality-of-life issues related to this neurological disease on both patients and caregivers.
- Cancer symptoms: The telltale sign of the fast-spreading disease to spot in your eyeson January 17, 2022 at 7:46 am
DESPITE the unprecedented gains made in Cancer research, the threat of the disease looms larger than ever. Scientific advancements promise to make the disease ever more survivable in coming years, but ...
- Tennis legend Chris Evert reveals ovarian cancer diagnosison January 17, 2022 at 5:16 am
In an ESPN article, Evert opens up about her battle with ovarian cancer and the importance of detecting the disease early.
- Improving diagnosis of Coronary Artery Disease: PCI optimization as the standard of elderly careon January 17, 2022 at 2:28 am
Coronary artery disease (CAD) or ischaemic heart disease (IHD) is the umbrella term used to denote conditions caused due to lack of blood flow to the heart.
via Bing News